Tag Archives: cancer

Rights and Responsibilities at the End of Life

Posted on June 23, 2016 by Center for Ethics and Humanities in the Life Sciences

By Hannah Giunta, MPH, PhD
Questions about end-of-life care are always vexing, but a recent article in U.S. News and World Report suggests that cancer patients continue to receive useless but harmful treatments at the end of life (Thompson, 2016). A new research study presented at the American Society of Clinical Oncology’s (ASCO’s) annual meeting revealed that a big part of the problem comes from a lack of meaningful dialogue among physicians, patients, and family members. Continue reading →

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , | 6 Comments

Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer

Posted on June 9, 2016 by Center for Ethics and Humanities in the Life Sciences

Center Professor Emerita Dr. Margaret Holmes-Rovner is a contributing author on a new article published in Annals of Family Medicine, “Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.” Published in the May/June 2016 issue, the study is … Continue reading →

Posted in Articles, Publications, Uncategorized | Tagged , , , , , | Comments Off on Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer

Why not more research into preventing cancer?

Posted on January 21, 2016 by Center for Ethics and Humanities in the Life Sciences

This post is a part of our Bioethics in the News series. For more information, click here. By Tom Tomlinson, PhD Why are so much money and effort put into research aimed at curing cancer, and so little devoted to preventing … Continue reading →

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , | 8 Comments

Why can it be difficult for oncologists to refuse patients late chemotherapy?

Posted on October 1, 2015 by Center for Ethics and Humanities in the Life Sciences

Oncologists’ decisions about administering late chemotherapy: What makes it so difficult? Event Flyer Background: An estimated 20-50% of incurable cancer patients receive chemotherapy in the last 30 days of life, although little data support this practice. Few studies have explored … Continue reading →

Posted in Bioethics Events, Brownbag & Webinar Series, Public Seminar Series | Tagged , , , , , , | Comments Off on Why can it be difficult for oncologists to refuse patients late chemotherapy?

Precision Medicine/Ambiguous Ethics?

Posted on February 19, 2015 by Center for Ethics and Humanities in the Life Sciences

This post is a part of our Bioethics in the News series. For more information, click here. By Leonard Fleck, PhD In his State of the Union Address President Obama announced that he wished to set aside $215 million for his … Continue reading →

Posted in Bioethics in the News | Tagged , , , , , | 11 Comments

The Joshua Hardy Case: Lessons Yet to Learn

Posted on March 20, 2014 by Center for Ethics and Humanities in the Life Sciences

This post is a part of our Bioethics in the News series. For more information, click here. By Hannah Giunta Earlier this month, major news outlets reported the story of 7-year-old Josh Hardy, a current end-stage cancer patient at St. Jude Children’s … Continue reading →

Posted in Bioethics in the News | Tagged , , , , , , , , , | 9 Comments

The “Jolie Effect”: Managing Awareness, Risk, and Personal Choices

Posted on June 11, 2013 by Center for Ethics and Humanities in the Life Sciences

This post is a part of our Bioethics in the News series. For more information, click here. By Monica List, DVM, MA On May 14, actress Angelina Jolie published an op-ed article in the New York Times (Jolie, 2013). In … Continue reading →

Posted in Bioethics in the News, Outreach | Tagged , , , , , , , , , | 2 Comments